That’s the future we’re building at GeneDx.
Comprehensive genomic insights. Precision medicine. Improved outcomes.
Discover how genetic testing could benefit your practice and your patients.
Learn moreSeptember 22, 2023
GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today announced that, effective as of October 1, the compensation committee of GeneDx’s board of directors granted newly-hired employees 133,998 restricted stock units (“RSUs”) as inducements material to each employee entering into employment with GeneDx.
September 11, 2023
Melanie Duquette joining team as Chief Growth Officer to drive commercial excellence, Jennifer Brendel to take new role as Chief of Corporate Affairs amplifying the GeneDx brand and leadership platform.
September 6, 2023
GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today announced a monumental accomplishment in its ongoing commitment to deliver personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery.